We are at the forefront of the introduction of innovative and advanced radiotherapy techniques. Our centres are equipped with the latest-generation linear accelerators and new modalities are offered as standard.

An innovative approach to metastatic prostate cancer and neuroendocrine tumours using peptide receptor radionuclide therapy (PRRT) to seek and destroy cancer cells.

We are following current evidence, leveraging our advanced technologies and following robust infection control procedures to ensure our patients continue to receive excellent care during the COVID-19 pandemic.